UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA

Clinical trials for UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for Tough-to-Treat lung cancer: testing a Triple-Drug attack

Disease control Ongoing

This study is testing if adding a new drug called pevonedistat to two standard chemotherapy drugs (carboplatin and paclitaxel) works better for people with advanced non-small cell lung cancer. It is for adults whose cancer has gotten worse after treatment with immunotherapy. The …

Matched conditions: UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA

Get alerted when new UNRESECTABLE LUNG NON-SQUAMOUS NON-SMALL CELL CARCINOMA trials appear

New hope for Tough-to-Treat lung cancer: testing a Triple-Drug attack